SCHEMBL1132483

SCHEMBL1132483

CC[N+](CC)(CC)C(Cl)Cl

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
KCNA1 Q09470 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28018964 0.96 KDM4E (0.35)
Hexane SCHEMBL9407318 0.87 TSHR (0.39) TSHR
Hexane SCHEMBL9407319 0.83 TSHR (0.39) TSHR
SCHEMBL2821216 0.81
Hydrochloric Acid SCHEMBL17509980 0.72 KDM4E (0.33) TSHR
SCHEMBL4360992 0.67
SCHEMBL16321131 0.65 TSHR (0.33) TSHR
SCHEMBL28035535 0.65
SCHEMBL349518 0.64 TSHR (0.33) TSHRNFKB1KCNA1
SCHEMBL2085974 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108853567-A Acrylate bone bonded adhesives 淄博市思瑞颖胶粘剂有限公司 2018-11-23 CN claimed
CN-108623781-A A kind of synthesis technology of aqueous polyurethane 南京宜凯瑞新材料有限公司 2018-10-09 CN claimed
CN-107446472-A A kind of waterborne polyester coating modified unsaturated polyester emulsion and preparation method thereof 合众(佛山)化工有限公司 2017-12-08 CN claimed
US-11566039-B2 Lincosamide antibiotics and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-01-31 US disclosed
CN-114509397-A Method for determining triethylamine content in solvent containing trace water by ultraviolet spectroscopy 甘肃银光聚银化工有限公司 2022-05-17 CN disclosed
US-20220033817-A1 Targeting Ligands SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT 2022-02-03 US disclosed
US-11174481-B2 Targeting ligands Arrowhead Pharmaceuticals, Inc. (US) 2021-11-16 US disclosed
US-20210087215-A1 LINCOSAMIDE ANTIBIOTICS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2021-03-25 US disclosed
EP-3383844-B1 PROCESS FOR THE PREPARATION OF CARBOPROST AND ITS TROMETHAMINE SALT CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT (HU) 2020-06-03 EP disclosed
US-10442762-B2 Process for the preparation of carboprost and its tromethamine salt CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA ZRT. (HU) 2019-10-15 US disclosed
US-20190256849-A1 Targeting Ligands SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT 2019-08-22 US disclosed
EP-0619317-A1 An expeditious synthesis of C-disaccharides using a temporary ketal connection CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1994-10-12 EP disclosed
EP-0617046-A1 Nucleoside derivatives and antiherpes composition NIPPON CHEMIPHAR CO., LTD. (JP) 1994-09-28 EP disclosed
EP-0422889-A2 Phenethanolamine compounds GLAXO GROUP LIMITED (GB) 1991-04-17 EP disclosed
US-4902684-A Benzazepine and benzothiazepine derivatives E. R. SQUIBB & SONS, INC. (US) 1990-02-20 US disclosed
US-4499293-A PGI2 Salts THE UPJOHN COMPANY (US) 1985-02-12 US disclosed
US-4338325-A PGI2 Pharmacologically acceptable salts THE UPJOHN COMPANY (US) 1982-07-06 US disclosed
US-4158667-A 6-Keto PGF analogs THE UPJOHN COMPANY (US) 1979-06-19 US disclosed
US-4055564-A Novel prostaglandin intermediates and process for the production thereof SYNTEX (U.S.A.) INC. (US) 1977-10-25 US disclosed
US-3998852-A NOVEL PROSTAGLANDIN INTERMEDIATES AND PROCESS FOR THE PRODUCTION THEREOF SYNTEX (U.S.A.) INC. (US) 1976-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220033817-A1 Targeting Ligands FABP1, SNRPE, HAVCR2 TSHR 2037/4885NFKB1 2422/4885KCNA1 4780/4885
US-10442762-B2 Process for the preparation of carboprost and its tromethamine salt PTGER4, PTGER1, PTGER2 TSHR 1143/4885NFKB1 1344/4885KCNA1 3679/4885
US-20190256849-A1 Targeting Ligands FABP1, SNRPE, HAVCR2 TSHR 2037/4885NFKB1 2422/4885KCNA1 4780/4885
US-11566039-B2 Lincosamide antibiotics and uses thereof NPEPPS, ASNS, LNPEP TSHR 4020/4885NFKB1 3516/4885KCNA1 4053/4885
US-20210087215-A1 LINCOSAMIDE ANTIBIOTICS AND USES THEREOF NPEPPS, ASNS, LNPEP TSHR 4020/4885NFKB1 3516/4885KCNA1 4053/4885
US-11174481-B2 Targeting ligands FABP1, SNRPE, HAVCR2 TSHR 2037/4885NFKB1 2422/4885KCNA1 4780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.